MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$15,603K
Net Income
-$23,527K
Net Profit Margin
-150.79%
EPS
-$6.62
Unit: Thousand (K) dollars
Revenue Breakdown
    • Product
    • License And Collaboration

Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
15,603 10,906 -5,423* 7,406
Cost of goods sold
3,610 1,673 -2,960* 2,316
Selling, general and administrative
27,673 21,104 2,321* 19,628
Research and development
600 186 238* 145
Amortization of intangible assets
1,043 1,031 -481* 679
Total operating expenses
32,926 23,994 -882* 22,768
Operating loss
-17,323 -13,088 -4,541* -15,362
Interest expense
2,389 2,353 753* -
Impairment of intangible assets
--71* -
Interest expense
---1,346
Change in fair value of convertible debt
-3,705 -9,632 -15,103* -
Interest income and other income
---10* 5
Total other expense
-6,094 -11,985 -15,937* -1,341
Net loss before provision for income taxes
-23,417 -25,073 -20,478* -16,703
Provision for income taxes
0 0 -6,689* -465
Net loss
-23,417 -25,073 -13,789 -
Change in fair value of convertible debt due to instrument credit risk
-110 2,188 --
Net loss and comprehensive loss
----16,238
Comprehensive loss
-23,527 -22,885 --
Basic EPS
-6.62 -7.57 -7.332 -5.3
Diluted EPS
-6.62 -7.57 -7.332 -5.3
Basic Average Shares
3,539,464 3,311,742 1,880,498* 3,061,488
Diluted Average Shares
3,539,464 3,311,742 1,880,498* 3,061,488
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Comprehensive loss-$23,527K Net loss-$23,417K (-578.96%↓ Y/Y)Change in fair value ofconvertible debt due to...-$110K Net loss beforeprovision for income taxes-$23,417K (-578.96%↓ Y/Y)Product$15,420K License AndCollaboration$183K Operating loss-$17,323K (-436.25%↓ Y/Y)Total other expense-$6,094K (-2688.81%↓ Y/Y)Total revenue$15,603K Total operatingexpenses$32,926K (919.25%↑ Y/Y)Change in fair value ofconvertible debt-$3,705K Interest expense$2,389K (993.28%↑ Y/Y)Selling, general andadministrative$27,673K Cost of goods sold$3,610K Amortization of intangibleassets$1,043K Research and development$600K (16.55%↑ Y/Y)

Pelthos Therapeutics Inc. (PTHS)

Pelthos Therapeutics Inc. (PTHS)